Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple‐negative breast cancer

BACKGROUND: Although neoadjuvant chemotherapy (NAC) is currently the best therapy for triple‐negative breast cancer (TNBC), resistance still occurs in a considerable proportion, thus it is crucial to understand resistance mechanisms and identify predictive biomarkers for patients selection. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yanhui, Zhang, Hongfei, Pan, Chaohu, He, Gao, Cui, Xiaoli, Yu, Xiafei, Zhang, Xiaoqiang, Wu, Dongfang, Yang, Junzhe, Wu, Xian, Luo, Haitao, Liu, Xiaoan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028167/
https://www.ncbi.nlm.nih.gov/pubmed/36271505
http://dx.doi.org/10.1002/cam4.5372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028167/
https://www.ncbi.nlm.nih.gov/pubmed/36271505
http://dx.doi.org/10.1002/cam4.5372

Ejemplares similares